BNP Paribas Discount Zert MHL 30..../ DE000PC2LN49 /
2024-05-13 8:54:04 AM | Chg.-0.18 | Bid10:00:38 PM | Ask10:00:38 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
351.91EUR | -0.05% | - Bid Size: - |
- Ask Size: - |
S+P GLOBAL INC. ... | - - | 2024-12-30 | Call |
GlobeNewswire
12:15 AM
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of April 2024
GlobeNewswire
12:00 AM
ARMLOGI HOLDING CORP. ANNOUNCES PRICING OF $8 MILLION INITIAL PUBLIC OFFERING
GlobeNewswire
12:00 AM
ROSEN, A LEADING LAW FIRM, Encourages Shoals Technologies Group, Inc. Investors With Losses in Exces...
GlobeNewswire
05-13
Synaptics to Participate at Upcoming Investor Conference on Monday, May 20, 2024
GlobeNewswire
05-13
ROSEN, THE FIRST FILING FIRM, Encourages Sonder Holdings Inc. Investors With Losses in Excess of $10...
GlobeNewswire
05-13
Encore Capital Group, Inc. Announces Pricing of Upsized Senior Secured Notes Offering
GlobeNewswire
05-13
Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-13
Pedrosa, an investor relations IR company included in OTC Markets' Premium Provider Directory, expan...
GlobeNewswire
05-13
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business ...
GlobeNewswire
05-13
Brilliant Earth Announces Participation in 19th Annual Needham Technology, Media, & Consumer Confere...
GlobeNewswire
05-13
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
05-13
Chocxo Dark Milk Chocolate Snaps Named a Winner in Good Housekeeping’s 2024 Best Snack Awards
GlobeNewswire
05-13
Farmers & Merchants Bancorp (FMCB) ranked #6 on Forbes Magazine’s List of “America’s Best Banks” for...
GlobeNewswire
05-13
Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
GlobeNewswire
05-13
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
GlobeNewswire
05-13
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights